Bacteriophages have been used therapeutically to treat infectious bacterial diseases for over a century. As ...

Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

LCGC International spoke with Dave Bell about the key developments he expects to influence chromatography in 2026. Drawing on ...

A recap of the morning session focused on method development, from Day 2 of HPLC 2025. Method development in LC remains a complex, expertise-heavy process, but emerging AI tools offer new promise for ...

Dipti Mehta has worked as a Senior Application Scientist at Revvity since 2022. Her research in DNA and protein assay development with LabChip GX Touch technology has generated new commercial assays.

Gene therapy represents one of the fastest growing biotherapeutics worldwide, with AAV at the forefront. This rapid growth is constantly challenging CMC approaches, from manufacturing through release ...

Sulfonamide resistance genes (sul genes) have a high detection rate and strong transmissibility. Therefore, there is an urgent need to develop more efficient detection methods to enhance the ...

Adenoassociated virus (AAV) has secured its spot as a preferred viral vector for gene therapies largely because of its ability to sustain long-term gene expression and relatively good safety profile.

New company unveiled at the annual ISCT conference in New Orleans combines two tenured and innovative CDMOs with a testing powerhouse The company currently manufactures two commercial cell therapies ...

To enhance the efficiency of the analytical method development process, Almac Sciences worked in collaboration with S-Matrix to test the Fusion QbD® software platform. Optimisation of a peptide and ...